INDA vs XBI
iShares MSCI India ETF vs SPDR S&P Biotech ETF
INDA$49.82
iShares MSCI India ETF
Indian large- and mid-cap equities.
Expense: 0.61%Yield: 0.00%
XBI$133.66
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.34%
Quick take
- • XBI has the lower expense ratio at 0.35% vs 0.61% for INDA.
- • XBI pays a higher dividend yield (0.34%).
Side-by-side metrics
| Metric | INDA | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.61% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $6.59B | $8.30B |
YTD return | -7.44% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.56 | 1.09 |
P/E ratio | 21.77 | — |
Last price | $49.82 | $133.66 |
Inception | — | — |
Issuer | iShares | State Street |
INDA top holdings
Top holdings · INDA
| HDFCBANK.NS | HDFC Bank Ltd | 6.58% |
| RELIANCE.NS | Reliance Industries Ltd | 6.44% |
| ICICIBANK.NS | ICICI Bank Ltd | 4.89% |
| BHARTIARTL.NS | Bharti Airtel Ltd | 3.60% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 3.34% |
| INFY.NS | Infosys Ltd | 2.81% |
| AXISBANK.BO | Axis Bank Ltd | 2.21% |
| M&M.NS | Mahindra & Mahindra Ltd | 2.18% |
| LT.NS | Larsen & Toubro Ltd | 2.05% |
| 500034 | Bajaj Finance Ltd | 1.93% |
Sector breakdown · INDA
Real Estate1.4%
Consumer Cyclical12.4%
Basic Materials8.6%
Consumer Defensive6.3%
Technology8.2%
Communication Services4.6%
Financial Services28.3%
Utilities4.5%
Industrials10.3%
Energy9.4%
Healthcare6.1%
XBI top holdings
Top holdings · XBI
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
Sector breakdown · XBI
Financial Services0.2%
Healthcare99.8%
About INDA
INDA (iShares MSCI India ETF) is Indian large- and mid-cap equities. Managed by iShares, the fund carries $6.6B in assets under management, an expense ratio of 0.61%. Its largest holding is HDFC Bank Ltd (HDFCBANK.NS), which represents 6.6% of the portfolio. Real Estate is the fund's largest sector exposure at 1.4%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.